Stock Fundamentals

Company Information

Company Name
Akoya Biosciences Inc
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
NASDAQ
ISIN: US00974H1041
CIK: 0001711933
CUSIP: 00974H104
Currency: USD
Full Time Employees: 205
Phone: 855 896 8401
Fiscal Year End: December
IPO Date: Apr 16, 2021
Description:

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions for transforming discovery, clinical research, and diagnostics in North America, the Asia-Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. Akoya Biosciences, Inc. was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

Address:

100 Campus Drive, Marlborough, MA, United States, 01752

Directors & Officers

Name Title Year Born
Mr. Brian McKelligon President, CEO & Director 1969
Mr. John Frederick Ek CPA CFO & Principal Accounting Officer 1976
Dr. Niroshan Ramachandran Ph.D. Chief Business Officer 1975
Mr. Anthony Catalano Senior Vice President of Operations NA
Mr. Priyam Shah Senior Director of Business Development & Investor Relations Strategy NA
Ms. Jennifer Kamocsay Chief Legal Officer 1971
Dr. Pascal Bamford Ph.D. Chief Clinical Officer 1973
Mr. Rob C. Hart C.F.A., CFA, J.D. Secretary NA

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Blue Water Life Science Advisors, LLC 4.70M Jun 30, 2025 9.40% $4.83 0.00%
BlackRock Inc 1.61M Mar 31, 2025 3.23% $0.00 -1.55%
Vanguard Group Inc 1.19M Jun 30, 2025 2.39% $0.00 -13.98%
PARAGON Assoc & PARAGON Assoc II JV 671.00K Mar 31, 2025 1.34% $2.19 -16.23%
Geode Capital Management, LLC 566.98K Mar 31, 2025 1.14% $0.00 0.26%
State Street Corp 493.79K Mar 31, 2025 0.99% $0.00 13.30%
JPMorgan Chase & Co 411.61K Mar 31, 2025 0.82% $0.00 751.97%
Nuveen, LLC 393.18K Mar 31, 2025 0.79% $0.00 0.00%
UBS Group AG 281.96K Mar 31, 2025 0.56% $0.00 231.06%
Peddock Capital Advisors, LLC 234.72K Jun 30, 2025 0.47% $0.07 0.00%
Northern Trust Corp 231.22K Mar 31, 2025 0.46% $0.00 -7.64%
ExodusPoint Capital Management, LP 205.32K Jun 30, 2025 0.41% $0.00 0.00%
Goldman Sachs Group Inc 173.44K Jun 30, 2025 0.35% $0.00 73.82%
JBF Capital, Inc. 119.51K Jun 30, 2025 0.24% $0.02 0.00%
Morgan Stanley - Brokerage Accounts 113.70K Mar 31, 2025 0.23% $0.00 -12.38%
Millennium Management LLC 113.25K Mar 31, 2025 0.23% $0.00 0.00%
Virtu Financial LLC 101.99K Mar 31, 2025 0.20% $0.01 0.00%
Css LLC 96.01K Jun 30, 2025 0.19% $0.01 0.00%
Rhumbline Advisers 74.26K Mar 31, 2025 0.15% $0.00 131.68%
Marshall Wace Asset Management Ltd 73.88K Jun 30, 2025 0.15% $0.00 0.00%

Shares Statistics

Shares Outstanding: 49.95M
Shares Float: 12.59M
% Insiders: 7,257.90%
% Institutions: 6,979.80%
Short % Float: 8.72%

🏆 Top 10 Institutional Holders

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Blue Water Life Science Advisors, LLC 4.70M 9.40% ▲ 0.00% Jun 30, 2025
2 BlackRock Inc 1.61M 3.23% ▼ 1.55% Mar 31, 2025
3 Vanguard Group Inc 1.19M 2.39% ▼ 13.98% Jun 30, 2025
4 PARAGON Assoc & PARAGON Assoc II JV 671.00K 1.34% ▼ 16.23% Mar 31, 2025
5 Geode Capital Management, LLC 566.98K 1.14% ▲ 0.26% Mar 31, 2025
6 State Street Corp 493.79K 0.99% ▲ 13.30% Mar 31, 2025
7 JPMorgan Chase & Co 411.61K 0.82% ▲ 751.97% Mar 31, 2025
8 Nuveen, LLC 393.18K 0.79% ▲ 0.00% Mar 31, 2025
9 UBS Group AG 281.96K 0.56% ▲ 231.06% Mar 31, 2025
10 Peddock Capital Advisors, LLC 234.72K 0.47% ▲ 0.00% Jun 30, 2025

Valuation Metrics

Enterprise Value: $120.62M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $64.44M
EBITDA: $-30.01M
Book Value: $-0.12
Earnings/Share: $-0.96
Profit Margin: -59.45%
Operating Margin: -79.73%
ROA (TTM): -17.49%
ROE (TTM): -354.27%
Revenue (TTM): $79.96M
Revenue/Share (TTM): $1.61
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -9.30%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios (Yearly)

Financial Ratios (Quarterly)

Earnings History

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-12-31 2.61x 10.46x 0.94x -4.48x -2.14x
2023-12-31 3.45x 1.46x 0.70x -6.58x -1.72x
2022-12-31 3.03x 1.20x 0.67x -14.54x -1.20x
2021-12-31 5.09x 0.27x 0.36x -11.95x -0.93x
2020-12-31 1.67x 1.87x 0.76x -4.22x -3.43x
2019-12-31 1.93x -0.81x 1.34x -7.18x -2.55x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jun 11, 2024 Brian Mckelligon N/A Sale 7.50K $2.08 $15.60K
Jun 06, 2024 Brian Mckelligon N/A Sale 7.50K $2.01 $15.08K
Mar 20, 2024 Brian Mckelligon N/A Sale 7.50K $4.97 $37.28K
Mar 13, 2024 Brian Mckelligon N/A Sale 7.50K $4.94 $37.05K
Dec 19, 2023 Brian Mckelligon N/A Sale 7.50K $4.48 $33.60K
Sep 07, 2023 Frederic Pla N/A Purchase 20.00K $4.60 $92.00K
Jun 12, 2023 John Frederick Ek N/A Purchase 20.00K $5.00 $100.00K
Jun 12, 2023 Matthew Winkler N/A Purchase 203.39K $5.00 $1.02M
Jun 06, 2023 Brian Mckelligon N/A Sale 5.00K $5.71 $28.55K
Dec 14, 2022 Joseph Driscoll N/A Sale 24.61K $12.54 $308.65K
Dec 13, 2022 Garry Ph.D. Nolan N/A Sale 100.00 $13.25 $1.33K
Dec 02, 2022 Garry Ph.D. Nolan N/A Sale 1.10K $13.25 $14.58K
Nov 16, 2022 Garry Ph.D. Nolan N/A Sale 300.00 $13.25 $3.98K
Nov 14, 2022 Garry Ph.D. Nolan N/A Sale 600.00 $13.28 $7.97K
Nov 10, 2022 Garry Ph.D. Nolan N/A Sale 3.81K $13.31 $50.71K
Sep 14, 2022 Garry Ph.D. Nolan N/A Sale 8.31K $13.26 $110.12K
Sep 12, 2022 Garry Ph.D. Nolan N/A Sale 1.80K $13.30 $23.94K
Sep 09, 2022 Garry Ph.D. Nolan N/A Sale 22.19K $13.31 $295.36K
Sep 07, 2022 Brian Mckelligon N/A Sale 5.00K $12.83 $64.15K

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about AKYA.US!